Table 4. Prevalence* [95% confidence interval] of new blood pressure categories in Iranian women; SuRFNCD-2011 .
|
Age group (years) |
Normal n (%) [95%CI]* |
Elevated n (%) [95%CI] |
Hypertension | Total (%) | |
|
Stage 1 n (%) [95%CI] |
Stage 2 n (%) [95%CI] |
||||
| 20-24 | 513 (68.4) | 72 (10.0) | 146 (18.3) | 26 (3.3) | 757 (100.0) |
| [63.4, 73.1] | [7.31, 13.7] | [15.1, 22.0] | [2.08, 5.07] | ||
| 25-29 | 464 (56.5) | 61 (8.2) | 220 (27.7) | 58 (7.6) | 803 (100.0) |
| [51.7, 61.3] | [5.83, 11.3] | [23.3, 32.7] | [5.9, 9.7] | ||
| 30-34 | 304 (47.8) | 58 (9.2) | 166 (30.5) | 78 (12.4) | 606 (100.0) |
| [42.2, 53.5] | [6.36, 13.3] | [25.2, 36.4] | [9.6, 15.9] | ||
| 35-39 | 207 (44.1) | 44 (8.2) | 137 (28.6) | 90 (19.1) | 478 (100.0) |
| [38.2, 50.1] | [5.54, 12.1] | [24.8, 32.7] | [14.9, 24.1] | ||
| 40-44 | 153 (33.7) | 57 (11.4) | 137 (28.4) | 122 (26.5) | 469 (100.0) |
| [28.3, 39.5] | [8.24, 15.7] | [24.2, 33.0] | [21.8, 31.9] | ||
| 45-49 | 118 (25.6) | 49 (10.9) | 131 (31.5) | 137 (31.9) | 435 (100.0) |
| 50-54 | 113 (20.5) | 57 (10.4) | 168 (32.2) | 211 (36.8) | 549 (100.0) |
| [16.6, 25.1] | [7.02, 15.1] | [24.7, 40.8] | [29.5, 44.9] | ||
| 55-59 | 110 (16.6) | 58 (8.8) | 181 (29.5) | 284 (45.1) | 633 (100.0) |
| [13.3, 20.5] | [6.25, 12.2] | [25.7, 33.6] | [39.7, 50.6] | ||
| 60-64 | 91 (16.2) | 53 (9.5) | 159 (28.5) | 272 (45.9) | 575 (100.0) |
| [12.5, 20.7] | [6.73, 13.1] | [23.7, 33.8] | [41.6, 50.2] | ||
| 65-69 | 64 (13.3) | 45 (9.4) | 131 (26.6) | 257 (50.7) | 497 (100.0) |
| [9.76, 17.9] | [6.71, 13.0] | [21.1, 33.0] | [44.3, 57.0] | ||
| Total | 2137 (46.1) | 554 (9.6) | 1576 (26.3) | 1535 (18.0) | 5802 (100.0) |
| [42.8, 49.5] | [7.86, 11.7] | [24.5, 28.2] | [16.1, 20.1] | ||
*Weighted analysis; CI: Confidence interval.